Alpha Tau Medical Ltd(DRTS)

Biotechnology · Jerusalem, JM

$14.48-0.41 (-2.75%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

EV/EBIT Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBIT ratio is N/A as of 2026-10-06T20:01:56.624Z.

Stored calculation inputs

Calculation as of: 2026-10-06T20:01:56.624Z.

Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 1,307,918,684
Total debt · period ending 2026-06-30: 15,152,000
Cash · period ending 2026-06-30: 22,993,000
TTM operating income · period ending 2026-06-30: -50,427,000

FMP input reference: d0cade57d6bc8828dc71ac364ddc44a4328d7c948fb2699a56d4eea8e3f6e5b7

EV/EBITDA|EV/Sales|Operating Income|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

DRTS EV/EBIT Ratio Metrics

EV/EBIT RATIO

N/A

DRTS Competitors' EV/EBIT Ratio

DRTS

Alpha Tau Medical Ltd

Current

Market Cap

$1.31B

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

COAG

Hemab Therapeutics Holdings, Inc. Common Stock

vs DRTS

Market Cap

$1.33B

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

OMER

Omeros Corporation

vs DRTS

Market Cap

$1.34B

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INBX

Inhibrx Biosciences Inc.

vs DRTS

Market Cap

$1.37B

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ORIC

ORIC Pharmaceuticals, Inc.

vs DRTS

Market Cap

$1.24B

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

OMDA

Omada Health

vs DRTS

Market Cap

$1.23B

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CRON

Cronos Group Inc.

vs DRTS

Market Cap

$1.23B

EV/EBIT Ratio

60.28x

TTM Avg

63.01x

3Y Avg

63.01x

5Y Avg

63.01x

PNTG

The Pennant Group, Inc.

vs DRTS

Market Cap

$1.39B

EV/EBIT Ratio

29.39x

TTM Avg

29.70x

3Y Avg

32.28x

5Y Avg

57.69x

INNV

Innovage Holding Corp.

vs DRTS

Market Cap

$1.22B

EV/EBIT Ratio

19.15x

TTM Avg

131.59x

3Y Avg

131.59x

5Y Avg

72.61x

BRVE

Braveheart Bio, Inc.

vs DRTS

Market Cap

$1.40B

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBIT RATIO	TTM	3Y	5Y
Alpha Tau Medical Ltd (DRTS)	$1.31B	N/A	N/A	N/A	N/A
Hemab Therapeutics Holdings, Inc. Common Stock (COAG)vs ›	$1.33B	N/A	N/A	N/A	N/A
Omeros Corporation (OMER)vs ›	$1.34B	N/A	N/A	N/A	N/A
Inhibrx Biosciences Inc. (INBX)vs ›	$1.37B	N/A	N/A	N/A	N/A
ORIC Pharmaceuticals, Inc. (ORIC)vs ›	$1.24B	N/A	N/A	N/A	N/A
Omada Health (OMDA)vs ›	$1.23B	N/A	N/A	N/A	N/A
Cronos Group Inc. (CRON)vs ›	$1.23B	60.28x	63.01x	63.01x	63.01x
The Pennant Group, Inc. (PNTG)vs ›	$1.39B	29.39x	29.70x	32.28x	57.69x
Innovage Holding Corp. (INNV)vs ›	$1.22B	19.15x	131.59x	131.59x	72.61x
Braveheart Bio, Inc. (BRVE)vs ›	$1.40B	N/A	N/A	N/A	N/A

EV/EBIT Ratio Formula & Definition

EV/EBIT = Enterprise Value / EBIT (TTM)

Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/EBIT Ratio: N/A

DRTS EV/EBIT Ratio Metrics

DRTS Competitors' EV/EBIT Ratio

EV/EBIT Ratio Formula & Definition

Related Metrics